FDA Restricts Compounded GLP-1s as Drug Shortages Ease: Impact on Weight-Loss Treatments
In a significant move affecting the weight-loss and diabetes treatment landscape, the U.S. Food and Drug Administration (FDA) has..
In a significant move affecting the weight-loss and diabetes treatment landscape, the U.S. Food and Drug Administration (FDA) has..